Andrew H Ko Selected Research

Andrew H Ko Research Topics

Disease

48	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 05/2002
42	Neoplasms (Cancer) 03/2024 - 09/2005
28	Adenocarcinoma 10/2023 - 10/2005
6	Disease Progression 07/2023 - 06/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2016
5	Neoplasm Metastasis (Metastasis) 12/2023 - 07/2007
4	Carcinoma (Carcinomatosis) 12/2016 - 10/2012
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 06/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2017
2	Pathologic Complete Response 01/2024 - 12/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 09/2016
2	Hypertension (High Blood Pressure) 12/2016 - 10/2008
2	Liver Diseases (Liver Disease) 12/2016 - 06/2014
2	Cholangiocarcinoma 12/2014 - 06/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2014 - 10/2012
2	Circulating Neoplastic Cells 02/2012 - 10/2008
2	Neutropenia 09/2009 - 07/2007
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2021
1	Protein Deficiency 10/2021
1	Sepsis (Septicemia) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Cytopenia 07/2020
1	Malignant Hypertension 07/2020
1	Edema (Dropsy) 07/2020
1	Renal Insufficiency (Renal Failure) 07/2020
1	Thrombotic Microangiopathies 07/2020
1	Multiple Myeloma 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Lymphoma (Lymphomas) 01/2018

Drug/Important Bio-Agent (IBA)

29	Gemcitabine FDA Link 12/2023 - 09/2005
8	Bevacizumab (Avastin)FDA Link 12/2016 - 09/2005
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2023 - 09/2005
7	130-nm albumin-bound paclitaxelIBA 10/2023 - 09/2009
7	Irinotecan (Camptosar)FDA LinkGeneric 11/2017 - 02/2008
6	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 01/2016
6	Leucovorin (Folinic Acid)FDA Link 11/2017 - 01/2016
4	Monoclonal AntibodiesIBA 01/2024 - 10/2008
4	NivolumabIBA 01/2022 - 01/2020
4	Capecitabine (Xeloda)FDA Link 01/2019 - 07/2007
4	folfirinoxIBA 01/2019 - 03/2016
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2017 - 01/2016
4	Albumin-Bound Paclitaxel FDA Link 11/2017 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 12/2016 - 10/2008
3	sotigalimabIBA 01/2024 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2012
3	Immune Checkpoint InhibitorsIBA 10/2021 - 09/2016
3	pembrolizumabIBA 10/2021 - 10/2018
3	MesothelinIBA 11/2020 - 09/2019
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2020 - 09/2019
3	ErbB Receptors (EGF Receptor)IBA 09/2009 - 08/2007
3	Cisplatin (Platino)FDA LinkGeneric 10/2008 - 01/2006
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 01/2016
2	AntigensIBA 03/2024 - 10/2008
2	Chimeric Antigen ReceptorsIBA 11/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 09/2019
2	CarbohydratesIBA 12/2019 - 10/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 07/2014 - 10/2013
2	thiamine triphosphorate (TTP)IBA 06/2014 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 10/2008
2	Cetuximab (Erbitux)FDA Link 08/2012 - 09/2005
2	Tyrosine Kinase InhibitorsIBA 09/2009 - 03/2008
2	Dihydrotachysterol (AT 10)IBA 07/2007 - 01/2006
2	Cytotoxins (Cytolysins)IBA 10/2005 - 09/2005
1	EpitopesIBA 03/2024
1	Alanine (L-Alanine)FDA Link 12/2023
1	Pyruvic Acid (Pyruvate)IBA 12/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2023
1	Panitumumab (Vectibix)FDA Link 01/2023
1	RamucirumabIBA 01/2023
1	atezolizumabIBA 01/2023
1	PEGPH20IBA 01/2023
1	Thymidine Monophosphate (TMP)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	IpilimumabIBA 10/2020
1	Cancer VaccinesIBA 10/2020
1	LigandsIBA 10/2020
1	eculizumab FDA Link 07/2020
1	Taxoids (Taxanes)IBA 01/2020
1	VaccinesIBA 01/2020
1	cabazitaxel FDA Link 01/2020
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 12/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018
1	B7-H1 AntigenIBA 10/2018
1	HSP27 Heat-Shock ProteinsIBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	Antisense OligonucleotidesIBA 12/2017
1	apatorsenIBA 12/2017

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 07/2023 - 01/2006
33	Therapeutics 01/2023 - 05/2002
7	Neoadjuvant Therapy 01/2024 - 12/2014
7	Radiotherapy 01/2023 - 05/2002
5	Immunotherapy 01/2022 - 01/2018
4	Precision Medicine 01/2022 - 01/2009
2	Aftercare (After-Treatment) 12/2023 - 11/2018
2	Microspheres (Microsphere) 12/2016 - 06/2014
2	Combination Drug Therapy (Combination Chemotherapy) 01/2015 - 04/2014
1	Gastrectomy 10/2020
1	Ovariectomy (Oophorectomy) 01/2020